David Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health, has been appointed as a Companion of the Order of Australia in the Australian King\u2019s Birthday Honours List.
Research with the potential to change the lives of millions around the world suffering with mental illness has received a boost with the announcement of \u00a342.7m of government funding.
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also also correctly identified the original site of cancer in 85% of those cases.
A new cohort study has provided compelling evidence that quitting smoking can lead to improved mental health outcomes among people with and without mental health disorders, alleviating concerns raised by both clinicians and smokers.
The University of Oxford has held its position as the leading academic institution in the UK for generating spinout companies, according to a new report by data analyst firm Beauhurst.
Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.
Nearly one billion people worldwide suffer from some form of mental disorder, according to UN data, but relatively few can access the treatment they need. Innovative AI based therapy, developed by researchers at Oxford, is now enabling a greater number of people to get help.
Researchers from the universities of Oxford and Nottingham have found that despite substantial disruption to primary care services, the safety of GP prescribing in England was largely unaffected by the Covid-19 pandemic.
We regret to announce the passing of Professor Dominic Kwiatkowski, Professor of Tropical Paediatrics at the Nuffield Department of Medicine, and a renowned researcher who dedicated his life to the research on malaria. Prof Kwiatkowski passed away in April 2023 at the age of 69.
On Thursday 4 May, the Nuffield Department of Surgical Sciences (NDS) hosted a special information day for patients with prostate cancer participating in the WINGMEN clinical trial.
Developing better connections between ethnic minority patients and health care professionals could deliver more positive health care experiences for ethnic minority patients, according to a new study. The results have been published in PLOS ONE.
When so much time and effort goes into developing the best medical treatments, we expect them to be available when we need them. The same goes for addiction treatments, so it\u2019s worrying that two of the most effective drugs for quitting smoking aren\u2019t available in the UK.
Oxford Cancer is pleased to announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation.
This award from the National Coordinating Centre for Public Engagement is a significant landmark, indicating WIN's commitment to embedding support for public engagement.
A new population-based study of 22 million people shows that autoimmune disorders now affect about one in ten individuals. The work, published in The Lancet, also highlights important socioeconomic, seasonal, and regional differences for several autoimmune disorders and provides new clues on possible causes behind these diseases.
Professor James H Naismith FRSC FRSB FRS FRSE FMedSci MAE is to become the new Head of Oxford\u2019s Mathematical, Physical and Life Sciences (MPLS) Division.
![\"\"](\"https://www.medsci.ox.ac.uk/news/professor-david-hunter-appointed-as-a-companion-of-the-order-of-australia/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n